Dr. Benz has been part of a number of accomplishments at the institute. Under his tenure, fundraising at Dana-Farber grew to more than $200 million annually from a network of 300,000 donors, the number of patients seeking treatment at Dana-Farber tripled and revenues climbed from $265 million to more than $1 billion, according to the report.
Dr. Benz became the president and CEO of the cancer institute in 2000. Before assuming the presidency of the institute, he served as chairman of the Department of Medicine at the Johns Hopkins University School of Medicine and the Sir William Osler Professor of Medicine.
According to the report, Dr. Benz, a hematologist, plans to continue his research and his teaching role at Harvard Medical School after he retires.
More articles on executive moves:
Rare Genomics Institute announces new director and CEO
Edith Pemberton named CFO of East Morgan County Hospital
Scotland County Hospital names CMO
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.